An open-label Phase 1 study of NEO-PTC-01 in patients with advanced or metastatic melanoma

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508524-35-00

Acronym

NTC-001

Enrollment

Registered

2023-12-19

Start date

2020-12-01

Completion date

2025-03-26

Last updated

2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic melanoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026